WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
15 hedge funds and large institutions have $279K invested in Windtree Therapeutics in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$21.6K | |
| 2 | +$14K | |
| 3 | +$8.5K | |
| 4 |
Cetera Investment Advisers
Schaumburg,
Illinois
|
+$5.07K |
| 5 |
HF
HRT Financial
New York
|
+$5K |
Top Sellers
| 1 | -$42.9K | |
| 2 | -$14K | |
| 3 | -$6K | |
| 4 |
DM
Deerfield Management
New York
|
-$6K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$6K |